Plain-English translation of NCT06904820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new way to screen people for three serious viral infections—hepatitis B, hepatitis C, and HIV—in community settings where vulnerable people already spend time. Instead of asking people to come to hospitals or clinics, the researchers bring simple, fast screening tests directly to the community. The goal is to find out if this approach makes it easier for people who use drugs and other at-risk groups to get tested and connected to treatment.
Thousands of people in France are infected with hepatitis C but have never been tested or treated because they avoid traditional hospitals and clinics. This trial exists to find a better way to reach people who fall through the cracks of regular healthcare and to help them get diagnosed and treated in places where they already feel comfortable.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have screening tests done at community locations—places you may already go for services or support. The tests are quick and use two methods to check for hepatitis B, C, and HIV. You won't need to travel to a hospital or clinic; the testing comes to you in your community.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Enrollment target
~2,300 participants
Started
June 2025
Primary completion
June 2035
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marilyne DEBETTE-GRATIEN, MD
University Hospital, Limoges
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.